Ligand validation:3TF6

DBH: 2,3-DIHYDROXY-BENZOIC ACID

DBH is a Ligand Of Interest in 3TF6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TF6_DBH_A_216	32%	44%	0.143	0.831	1.14	1.03	-	-	0	0	91%	0.9091
3TF6_DBH_C_216	26%	33%	0.142	0.799	1.33	1.31	1	1	0	0	91%	0.9091
3TF6_DBH_B_216	15%	31%	0.212	0.788	1.32	1.41	1	2	0	0	91%	0.9091
3U0D_DBH_B_182	82%	20%	0.123	0.978	2.24	1.16	2	1	0	0	100%	1
3T1D_DBH_B_182	38%	43%	0.167	0.868	0.72	1.45	-	1	2	0	100%	1
3BY0_DBH_A_193	38%	59%	0.228	0.93	0.82	0.77	-	-	0	0	100%	1
3I0A_DBH_B_180	26%	64%	0.189	0.831	0.74	0.66	-	-	0	0	100%	1
3CMP_DBH_B_303	21%	63%	0.243	0.85	0.72	0.68	-	-	0	0	100%	1
9BHY_DBH_B_601	95%	44%	0.061	0.962	1.21	0.96	-	1	0	0	100%	0.988
8U9A_DBH_B_301	77%	62%	0.117	0.955	0.75	0.7	-	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.